Technical Operations is part of our Operations unit. We strive to deliver high quality, affordable medicines on time, every time, safely and efficiently, and become the top manufacturer of innovative and generic medicines in the industry - while keeping our patients at the heart of everything we do.

How do we aim to do it?

We play a critical role in enabling the company’s mission to reimagine medicine by providing the manufacturing technology that enables breakthrough medical innovation to deliver our medicines to patients. As Novartis continues to evolve, we are fundamentally transforming the way we work to match our capacity and capabilities to the changing demands of the product portfolio. Building on our strengths, we are re-imagining Technical Operations to continue to serve our patients and the business sustainably now and in the years to come.

As one of the largest divisions within Novartis, we take necessary actions to overcome headwinds via standardization, creating more value through our supplier relationships, network transformation / synergies and data & technology. We have committed to ambitious goals for the future of our operations that will help Novartis continue to reimagine manufacturing by making high quality medicines accessible to patients around the world.


Five integrated Manufacturing and Supply units with end-to-end responsibility for manufacturing, internal & external supply.

Large Molecules Platform

The Large Molecules Platform is based on synergies and interlinks between the Biotech Drug Substance sites (comprising management of cell banks, upstream and downstream processes) and Drug Product sites (that include formulation, filling under aseptic conditions and packaging).

Cell & Gene Therapy Platform

The Cell and Gene Therapy Platform mission is to collaboratively deliver timely access to cost-effective, quality, innovative medicines which improve and extend patient lives. The platform is responsible for the manufacturing of ground-breaking cell and gene therapies, including Chimeric Antigen Receptor T-Cell (CAR-T) therapy. This CAR-T therapy is tailored individually to and manufactured for each patient via pioneering technology. Currently the platform consists of three internal CAR-T manufacturing sites and four CMOs.

Small Molecules Platform

This platform aims to optimize and further enhance the end-to-end supply of small molecules innovative medicines products to become a top-class customer service center and reliable partner to our customers and patients.

Ophthalmology and Local Market Manufacturing

The Ophthalmology and Local Market Manufacturing (LMM) Platform's mission is to create, maintain and/or leverage patient & market access by driving focused ophthalmology business and creating local competitive advantages through Technical Operations value creation and innovation, by delivering affordable medicines to patients and becoming more agile.

Novartis Gene Therapies

The mission of Novartis Gene Therapies (GTx) is to become the global leader in gene therapy. From the lab to the patient, and every stop along the way, GTx is relentless in its dedication to developing and commercializing transformational gene therapies. Gene therapy stands at the very forefront of scientific advancement and is helping to usher in both a new way of treating genetic diseases and new futures for patients impacted by them.

Note: Contract Manufacturing - In addition to the above platforms, we recently launched Global Biotech Corporations. This new unit will focus on producing biologics and cell and gene products for other companies, leveraging our outstanding manufacturing assets, technology, and capabilities from different parts of our organization, and our highly skilled teams.


In Quality, our guiding purpose is to have a positive impact on patients. With a goal to go beyond compliance and look to serve our patients effectively, we are transforming to become an agile quality organization by –

  • simplifying our operations for efficiency
  • eliminating duplication and
  • innovating how we work

to focus on what really matters, making and supplying life-changing medicines to our patients.

Julian , Process Expert at Novartis

3 years, 4 sites, 3 production platforms. Having started as a trainee, I have since moved into a position which is central to our production organization where I am able to improve and stabilize processes by working closely with colleagues across different functions.

Julian, Process Expert

Why apply your skills and knowledge at Novartis?

We recognize career development stems from personal growth, and personal growth stems from experiences. We are ‘unbossed’ to drive our own personal growth, to feed our curiosity, and to challenge, stretch and enhance our skills and knowledge.

In addition to the innumerable learning & mentoring opportunities available, we have access to:

  • New Hire functional training programs
  • Technical Operations Innovation Studio
  • Site Head Academy
  • Capabilities building
  • Talent and Inclusion Development Programs


Find your Technical Operations career with Novartis.

Search Technical Operations Jobs